SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-18-000288
Filing Date
2018-01-09
Accepted
2018-01-09 06:32:36
Documents
1
Period of Report
2018-01-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-40685.html 4  
1 PRIMARY DOCUMENT marketforms-40685.xml 4 6462
  Complete submission text file 0001214659-18-000288.txt   7840
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Issuer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THE MEDICINES COMPANY 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address
Furse Brent (Reporting) CIK: 0001600752 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34637 | Film No.: 18517821